Publications:57
Book an Appointment
About Me
Dr. Albert D. Min is an expert on management of patients with chronic viral hepatitis, involved in numerous clinical trials of antiviral therapy both in hepatitis B and C, and has presented his research data at various national meetings. He is also involved extensively in managing and evaluating patients with end-stage liver disease for liver transplantation. In addition, he is interested in early detection of possible primary liver cancer and its outcome in patients with underlying chronic liver disease. As the Director of the Liver Clinic at Mount Sinai he is closely involved in the teaching of liver and gastroenterology fellows on consultative hepatology practice.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
About Me
Dr. Albert D. Min is an expert on management of patients with chronic viral hepatitis, involved in numerous clinical trials of antiviral therapy both in hepatitis B and C, and has presented his research data at various national meetings. He is also involved extensively in managing and evaluating patients with end-stage liver disease for liver transplantation. In addition, he is interested in early detection of possible primary liver cancer and its outcome in patients with underlying chronic liver disease. As the Director of the Liver Clinic at Mount Sinai he is closely involved in the teaching of liver and gastroenterology fellows on consultative hepatology practice.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Clinical Focus
- General Consultation
Education
MD, University of Rochester School of Medicine/Dentistry
Research Fellow, Liver Research Center, The Albert Einstein College of Medicine
, Unified Training Program of The Albert Einstein College of Medicine and Montefiore Medical Center
Residency, Internal Medicine
Stony Brook University Hospital
Fellowship, Gastroenterology
Albert Einstein College of Medicine-Yeshiva University
Certifications
American Board of Internal Medicine
Awards
1990
Senior Research Fellow Award
American Gastroenterological Association
1981
Phi Beta Kappa
Research
Viral Hepatitis, Hepatitis B, Hepatitis C, Cirrhosis, Hepatocellular carcinoma, Liver Transplantation
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
- Physician Office10 Union Square, Suite 2H/J, New York, NY, 10003
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- An expert consensus for the management of chronic hepatitis B in Asian Americans. M. J. Tong, C. Q. Pan, S. H.B. Han, D. S.K. Lu, S. Raman, K. Q. Hu, J. K. Lim, H. W. Hann, A. D. Min. Alimentary Pharmacology and Therapeutics
- Low-level viremia in hepatitis b patients on antiviral treatment: Can we ignore it?. Albert D. Min. Hepatology
- Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study. Joseph Ahn, Joseph K. Lim, Hannah M. Lee, Anna S. Lok, Mindie Nguyen, Calvin Q. Pan, Ajitha Mannalithara, Helen Te, K. Rajender Reddy, Huy Trinh, Danny Chu, Tram Tran, Daryl Lau, Truong Sinh Leduc, Albert Min, Loc Trong Le, Ho Bae, Sang Van Tran, Son Do, Hie Won L. Hann, Clifford Wong, Steven Han, Anjana Pillai, James S. Park, Myron Tong, Steve Scaglione, Jocelyn Woog, W. Ray Kim. American Journal of Gastroenterology
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
Care Provider’s Concern
Likelihood to Recommend Care Provider
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Min during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Intercept Pharmaceuticals Inc.
- Gilead Sciences, Inc.
- Novo Nordisk, Inc.
- AbbVie Inc.
- Madrigal Pharmaceuticals, Inc
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Min during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Intercept Pharmaceuticals Inc.
- Gilead Sciences, Inc.
- Novo Nordisk, Inc.
- AbbVie Inc.
- Madrigal Pharmaceuticals, Inc
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.